In vitro efficacy of ciprofloxacin alone and in combination with amoxycillin against Salmonella typhi isolates

Indian Journal of Experimental Biology

Volumn 41, Issue 4, 2003, Pages 360-362

  Mandal, S ^a   Mandal, Manisha ^a   Pal, N K ^a  

^a CALCUTTA SCHOOL OF TROPICAL MEDICINE   (India)

Author keywords

[No Author keywords available]

Indexed keywords

ADDITIVES; BACTERIA;

CIPROFLOXACIN; CLINICAL ISOLATES;

ANTIBIOTICS;

AMOXICILLIN; CIPROFLOXACIN;

ARTICLE; DRUG COMBINATION; DRUG EFFECT; DRUG POTENTIATION; HUMAN; IN VITRO STUDY; ISOLATION AND PURIFICATION; MICROBIOLOGICAL EXAMINATION; SALMONELLA TYPHI;

AMOXICILLIN; CIPROFLOXACIN; DRUG SYNERGISM; DRUG THERAPY, COMBINATION; HUMANS; MICROBIAL SENSITIVITY TESTS; SALMONELLA TYPHI;

SALMONELLA; SALMONELLA TYPHI;

EID: 0037383378     PISSN: 00195189     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (16)

1. Kumar P D, Ray P & Sengal R, Ciprofloxacin for typhoid fever, Lancet, 338 (1991) 1143.
2. Threlfall E J, Ward L R, Skinner J A, Smith H R & Lacey S, Ciprofloxacin resistant Salmonella typhi and treatment failure, Lancet, 353 (1999) 1590.
3. Murdoch D H, Banatvala N A, Bone A, Shoismatulloev B I, Ward L R & Threlfall E J, Epidemic ciprofloxacin resistant Salmonella typhi in Tajikistan, Lancet, 351 (1998) 339.
4. Saha M R, Dutta P, Niyogi S K, Dutta S, Mitra U, Ramamurthy T, Manna B & Bhattacharya S K, Decreasing trend in the occurrence of Salmonella enterica serotype Typhi amongst hospitalized children in Kolkata, India during 1990-2000, Indian J Med Res, 115 (2002) 46.
5. Dutta P, Mitra U, Dutta S, De A, Chatterjee M K & Bhattacharya S K, Ceftriaxone therapy in ciprofloxacin treatment failure typhoid fever in children, Indian J Med Res, 113 (2001) 210.
6. Bauer A W, Kirby W M, Sherris J C & Turk M, Antibiotic susceptibility testing by a standardized single disc method, Am J Clin Pathol, 45 (1966) 493.
7. Miles R S & Amyes S G B, Laboratory control of antimicrobial therapy, in Mackie and McCartny Practical Medical Microbiology, edited by J G Collee, A G Fraser, B P Marmion and A Simmons (Churchill Livingstone, New York) 1986, 151.
8. Leclercq R, Bingen E, Su, Q H, Lambert-Zechovski N, Courvalin P & Duval J, Effects of combinations of β-lactams, daptomycin, gentamycin and glycopeptides against glycopeptide resistant Enterococci, Antimicrob Agents Chemther, 35 (1991) 92.
9. Wolfson J S & Hooper D C, Fluoroquinolone antimicrobial agents, Clin Microbiol Rev, 2 (1989) 378.
10. Eliopoulos G M & Eliopoulos C T, Ciprofloxacin in combination with other antimicrobial, Am J Med, 87 (1989) 17.
11. Huovinen P, Wolfson, J S & Hooper D C, Synergism of trimethoprim and ciprofloxacin against clinical bacterial isolates, Eur J Clin Microbiol Infect Dis, 11 (1992) 255.
12. Komatsuzawa H, Suzuki J, Sugal M, Miyake Y & Suginaka H, Effect of combination of oxacillin and non β-lactam antibiotics on methicillin resistant Staphylococcus aureus, J Antimicrob Chemother, 33 (1994)1155.
13. Climo W M, Patron R L & Archer G L, Combination of vancomycin and β-lactams are synergistic against staphylococci with reduced susceptibility to vancomycin, Antimicrob Agents Chemother, 43 (1999) 1747.
14. Haraga I, Nomura S & Nagayama A, The effects of vancomycin and β-lactam antibiotics against vancomycin low-level or intermediately resistant Staphylococcus aureus, New Eng J Med, 341 (1999) 1624.
15. Howe R A, Wootton M, Bennett M, MacCwan A P & Walsh T R, Interactions between methicillin and vancomycin in methicillin resistant Staphylococcus aureus strains displaying different phenotype of vancomycin susceptibility, J Clin Microbiol, 37 (1999) 3068.
16. Aritaka N, Hanaki H, Cui L & Hiramatsu K, Combination effect of vancomycin and β-lactams against a Staphylococcus aureus strains, Mu3, with heterogenous resistance to vancomycin, Antimicrob Agents Chemother, 45 (2001) 1292.